Valuation: ACC Aviation Holdings Ltd.

Market Cap 12.8M 11.19M 10.32M 9.51M 17.93M 1.23B 18.33M 123M 48.52M 604M 48.07M 47.01M 2.08B P/E 2018
-2.8x
P/E 2019 -4.3x
Enterprise Value 13.14M 11.49M 10.6M 9.77M 18.41M 1.27B 18.82M 127M 49.83M 620M 49.36M 48.28M 2.13B EV / Sales 2018
-
EV / Sales 2019 -
Free-Float
49.79%
Yield 2018 *
-
Yield 2019 -
1 day-20.00%
Current month-20.00%
1 month-29.58%
3 months+400.00%
6 months+900.00%
Current year+492.42%
1 month 0.56
Extreme 0.5556
1.27
Current year 0.05
Extreme 0.051
1.42
1 year 0.02
Extreme 0.0152
1.42
3 years 0.02
Extreme 0.0152
2.5
5 years 0.02
Extreme 0.0152
2.5
10 years 0.02
Extreme 0.0152
5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 2018-10-31
Chief Executive Officer - -
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/7/20 Fiscal year

Chief Executive Officer

1,512,525 12.1948%
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%0.00%+316.84%+207.22% 499M
-0.96%-6.95% - - 806M
-0.10%-0.20% - - 642M
+1.33%-4.14% - - 643M
+0.56%+0.85% - - 611M
-0.14%-0.05% - - 596M
-0.10%-0.44% - - 596M
-1.53%-1.53% - - 575M
-2.80%+8.17%+241.94%-71.63% 563M
Average -2.64%-0.48%+279.39%+67.79% 614.51M
Weighted average by Cap. -2.21%-0.80%+277.15%+59.43%

Financials

2018 2019
Net sales - -
Net income -3.45M -3.02M -2.78M -2.56M -4.83M -332M -4.94M -33.26M -13.08M -163M -12.96M -12.67M -560M -2.77M -2.42M -2.23M -2.06M -3.88M -267M -3.96M -26.68M -10.49M -131M -10.4M -10.17M -449M
Net Debt -714K -624K -576K -531K -1M -68.8M -1.02M -6.89M -2.71M -33.69M -2.68M -2.62M -116M 345K 301K 278K 256K 483K 33.2M 494K 3.32M 1.31M 16.26M 1.29M 1.27M 55.98M
Logo ACC Aviation Holdings Ltd.
ACC Aviation Holdings Ltd, formerly Elfato Inc, is an Israel-based company engaged in the business of developing nano-cannabis powder. The Company focuses on the development and production of commercially-viable cannabis powder-based drugs for medical uses. Cannapowder Inc's research and development programs main objective is to identify active pharmaceutical ingredient, such as cannabidiol (CBD), cannabinol (CBN) and tetrahydrocannabidiol (THC). The active ingredients interact with body receptors and help in controlling bodily reactions such as inflammation and pain. The Company's objective is to establish and operate several production facilities, each located in separate territories. The Company operates through its subsidiary, Canna Powder Israel.
Employees
3
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. CAVG Stock